Agenus | AGEN - Operating Expenses

Agenus reported $88.08M in Operating Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
Agenus AGEN:US USD 88.08M 23.66M
Amgen AMGN:US USD 4.61B 695M
AstraZeneca AZN:LN USD 10.11B 376M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Celldex Therapeutics CLDX:US USD 29.5M 1.4M
CSL CSL:AU USD 5.05B 1.24B
Dynavax Technologies DVAX:US USD 121.36M 15.02M
Eli Lilly And LLY:US USD 5.47B 200.3M
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Glaxosmithkline GSK:US GBP 5.51B 1.13B
Immunogen IMGN:US USD 100.73M 7.92M
Intrexon XON:US USD 23.56M 776K
Jiangsu Hengrui Me. 600276:CH CNY 4.46B 747.46M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Karyopharm Therapeutics KPTI:US USD 67.45M 465K
Macrogenics MGNX:US USD 61.12M 5.57M
Merck MRK:GR EUR 4.77B 199M
Merk MRK:US USD 10.32B 624M
Northwest Biotherapeutics NWBO:US USD 16.28M 5.41M
Novartis NOVN:VX USD 11.05B 378M
Novavax NVAX:US USD 601.28M 260.49M
Pfizer PFE:US USD 19.12B 5.9B
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Rigel Pharmaceuticals RIGL:US USD 49.2M 8.39M
Sangamo Biosciences SGMO:US USD 82.62M 1.27M
Veracyte VCYT:US USD 85.72M 445K
YTE INCY:US USD 856.61M 171.68M